News

The new agreement is to focus on detecting genetic abnormalities in Cell-free DNA and embryo biopsies.

The Rubicon acquisition will allow the Takara Bio Group to augment and expand its worldwide commercial offerings in next generation sequencing (NGS) sample preparation and expand into new markets.

Information useful to plant scientists as well as researchers in the fields of biofuels, materials science, and secondary plant metabolism.

Study sheds light on an ancient cellular mechanism that makes cancer cells invasive.

Electrogenetic device has the potential to allow scientists to control biology.

The U.S. Environmental Protection Agency and the U.S. Food and Drug Administration issued final advice regarding fish consumption, geared toward helping women who are pregnant and breastfeeding mothers make informed choices when it comes to safe to eat.

The microscope can image and analyze DNA sequences and genetic mutations without having to first extract DNA from samples, making use in remote locations possible.

The collaboration will grant Taiho access to X-Chem’s DEX™ technology which is based on DNA-encoded libraries of small molecules with more than 120 billion molecules.

Addition of Monolith NT from NanoTemper Technologies Ltd. enables Domainex to offer a unique protein production, characterisation, and fragment screening service.

Pall ForteBio will acquire the assets related to SensiQ's Pioneer product line.